BridgeBio Pharma, Inc. - Common Stock (NQ:BBIO)

67.25 +0.34 (+0.51%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BridgeBio Pharma, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

BridgeBio Pharma Presents Updated Encouraging Clinical and Biomarker Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

May 22, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma to Present Updated Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

May 15, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 11, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About BridgeBio Pharma ↗

April 13, 2023

Via Benzinga

2 Best Growth Stocks to Buy in April ↗

April 03, 2023

Takeover interest is spurring these two biotech stocks higher.

Via The Motley Fool

BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update

May 04, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference

April 27, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

Second Quarter Outlook For Biotech Stocks ↗

April 25, 2023

Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity.

Via Talk Markets

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 11, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

4 Analysts Have This to Say About BridgeBio Pharma ↗

March 07, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 07, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023 ↗

April 19, 2023

Via Benzinga

Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns ↗

March 31, 2023

The first quarter of 2023 was positive for the U.S. stock market as a whole, with the S&P 500 index faithfully tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), rising by 6%.

Via Benzinga

Stocks Rise As Investors Bet On Bank Recovery ↗

March 29, 2023

Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.

Via Talk Markets

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories ↗

March 27, 2023

Benzinga

Via Benzinga

Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest ↗

March 27, 2023

BridgeBio Pharma Inc (NASDAQ: BBIO) is reportedly attracting takeover interest as some large pharmaceutical companies are studying a potential acquisition of the biotech firm.

Via Benzinga

First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 27, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab)

March 23, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)

March 21, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio Pharma to Present Preliminary Findings on its Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)

March 17, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope

March 14, 2023

BridgeBio’s recent volatility is a perfect example of how good news often turns into bad news for biopharmaceutical companies.

Via MarketBeat

Topics Economy

Why BridgeBio Pharma Shares Are Falling Sharply ↗

March 08, 2023

BridgeBio Pharma Inc (NASDAQ: BBIO) shares are trading lower by 15.8% to $15.62 Wednesday morning after the company priced an offering of 8.82 million shares at $17 per share.

Via Benzinga

After FDA Delays Hemophilia Gene Therapy, BioMarin's Dwarfism Drug Under FDA Review For Expanded Use ↗

March 08, 2023

Via Benzinga

BridgeBio Pharma Announces Pricing of Public Offering of Common Stock

March 08, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗

March 07, 2023

Via Benzinga

Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗

March 07, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

March 06, 2023

Via Benzinga

BridgeBio Pharma Announces Proposed Public Offering of Common Stock

March 06, 2023

From BridgeBio Pharma, Inc.

Via GlobeNewswire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.